Negative_JJ
regulation_NN
of_IN
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
expression_NN
in_IN
monocytes_NNS
:_:
role_NN
of_IN
the_DT
65-kDa_JJ
plus_CC
50-kDa_JJ
NF-kappa_NN
B_NN
dimer_NN
._.

Although_IN
monocytic_JJ
cells_NNS
can_MD
provide_VB
a_DT
reservoir_NN
for_IN
viral_JJ
production_NN
in_FW
vivo_FW
,_,
their_PRP$
regulation_NN
of_IN
human_JJ
immunodeficiency_NN
virus_NN
type_NN
1_CD
-LRB-_-LRB-
HIV-1_NN
-RRB-_-RRB-
transcription_NN
can_MD
be_VB
either_CC
latent_JJ
,_,
restricted_JJ
,_,
or_CC
productive_JJ
._.

These_DT
differences_NNS
in_IN
gene_NN
expression_NN
have_VBP
not_RB
been_VBN
molecularly_RB
defined_VBN
._.

In_IN
THP-1_NN
cells_NNS
with_IN
restricted_JJ
HIV_NN
expression_NN
,_,
there_EX
is_VBZ
an_DT
absence_NN
of_IN
DNA-protein_JJ
binding_NN
complex_NN
formation_NN
with_IN
the_DT
HIV-1_NN
promoter-enhancer_NN
associated_VBN
with_IN
markedly_RB
less_JJR
viral_JJ
RNA_NN
production_NN
._.

This_DT
absence_NN
of_IN
binding_NN
was_VBD
localized_JJ
to_TO
the_DT
NF-kappa_NN
B_NN
region_NN
of_IN
the_DT
HIV-1_NN
enhancer_NN
;_:
the_DT
65-kDa_JJ
plus_CC
50-kDa_JJ
NF-kappa_NN
B_NN
heterodimer_NN
was_VBD
preferentially_RB
lost_VBN
._.

Adding_VBG
purified_VBN
NF-kappa_NN
B_NN
protein_NN
to_TO
nuclear_JJ
extracts_NNS
from_IN
cells_NNS
with_IN
restricted_JJ
expression_NN
overcomes_VBZ
this_DT
lack_NN
of_IN
binding_NN
._.

In_IN
addition_NN
,_,
treatment_NN
of_IN
these_DT
nuclear_JJ
extracts_NNS
with_IN
sodium_NN
deoxycholate_NN
restored_VBD
their_PRP$
ability_NN
to_TO
form_VB
the_DT
heterodimer_NN
,_,
suggesting_VBG
the_DT
presence_NN
of_IN
an_DT
inhibitor_NN
of_IN
NF-kappa_NN
B_NN
activity_NN
._.

Furthermore_RB
,_,
treatment_NN
of_IN
nuclear_JJ
extracts_NNS
from_IN
these_DT
cells_NNS
that_WDT
had_VBD
restricted_JJ
expression_NN
with_IN
lipopolysaccharide_NN
increased_VBD
viral_JJ
production_NN
and_CC
NF-kappa_NN
B_NN
activity_NN
._.

Antiserum_NN
specific_JJ
for_IN
NF-kappa_NN
B_NN
binding_NN
proteins_NNS
,_,
but_CC
not_RB
c-rel-specific_JJ
antiserum_NN
,_,
disrupted_VBD
heterodimer_NN
complex_NN
formation_NN
._.

Thus_RB
,_,
both_DT
NF-kappa_NN
B-binding_JJ
complexes_NNS
are_VBP
needed_VBN
for_IN
optimal_JJ
viral_JJ
transcription_NN
._.

Binding_NN
of_IN
the_DT
65-kDa_JJ
plus_CC
50-kDa_JJ
heterodimer_NN
to_TO
the_DT
HIV-1_NN
enhancer_NN
can_MD
be_VB
negatively_RB
regulated_VBN
in_IN
monocytes_NNS
,_,
providing_VBG
one_CD
mechanism_NN
restricting_VBG
HIV-1_NN
gene_NN
expression_NN
._.

